Clinical Trial Update: Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing lenalidomide in combination with a vaccine therapy for patients with early-stage asymptomatic chronic lymphocytic leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Vaccine therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ann Arbor Stage I Small Lymphocytic Lymphoma, Ann Arbor Stage II Small Lymphocytic Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-08-22